Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 8/20 | 0.55 |
| ▸ | HSP90AA1 | P07900 | 5/20 | 0.48 |
| ▸ | CCR6 | P51684 | 3/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.48 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.48 |
| ▸ | PKM | P14618 | 2/20 | 0.48 |
| ▸ | APOBEC3G | Q9HC16 | 2/20 | 0.48 |
| ▸ | G6PD | P11413 | 2/20 | 0.48 |
| ▸ | HTT | P42858 | 2/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.46 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29485051 | 1.00 | MGLL (0.55) | MGLLHSP90AA1CCR6ALDH1A1NPSR1 | |
| SCHEMBL26667212 | 0.82 | MGLL (0.57) | MGLLHSP90AA1CCR6ALDH1A1NPSR1 | |
| SCHEMBL9067561 | 0.82 | TLR9 (0.54) | MGLLHSP90AA1CCR6ALDH1A1NPSR1 | |
| SCHEMBL11614476 | 0.81 | MEN1 (0.50) | MEN1KMT2ATDP1MAPTMETAP2 | |
| SCHEMBL29485049 | 0.80 | MGLL (0.59) | MGLLHSP90AA1CCR6ALDH1A1NPSR1 | |
| SCHEMBL717739 | 0.80 | MGLL (0.59) | MGLLHSP90AA1CCR6ALDH1A1NPSR1 | |
| SCHEMBL5075617 | 0.80 | MGLL (0.59) | MGLLHSP90AA1CCR6ALDH1A1NPSR1 | |
| SCHEMBL30464215 | 0.80 | MGLL (0.59) | MGLLHSP90AA1CCR6ALDH1A1NPSR1 | |
| SCHEMBL10587456 | 0.78 | MGLL (0.57) | MGLLHSP90AA1ALDH1A1NPSR1PKM | |
| SCHEMBL17867050 | 0.78 | MGLL (0.54) | MGLLHSP90AA1CCR6ALDH1A1NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-100335559-C | High optical contrast resin composition and electronic package utilizing same | IBM (US) | 2007-09-05 | — | — | CN | claimed |
| CN-1226580-A | High optical contrast resin composition and electronic package utilizing same | IBM (US) | 1999-08-25 | — | — | CN | claimed |
| EP-4061961-B1 | METHOD FOR DOUBLE STRAND SEQUENCING | OXFORD NANOPORE TECH PLC (GB) | 2026-04-08 | — | — | EP | disclosed |
| US-20260072008-A1 | METHOD OF CHARACTERISING A PEPTIDE, POLYPEPTIDE OR PROTEIN USING A NANOPORE | UNIV OXFORD INNOVATION LTD (GB) | 2026-03-12 | — | — | US | disclosed |
| US-20260072009-A1 | METHOD OF CHARACTERISING A TARGET POLYPEPTIDE USING A NANOPORE | OXFORD NANOPORE TECHNOLOGIES PLC (GB) | 2026-03-12 | — | — | US | disclosed |
| US-20260063618-A1 | METHOD OF CHARACTERISING A TARGET POLYPEPTIDE USING A NANOPORE | Oxford Nanopore Technolgies PLC (GB) | 2026-03-05 | — | — | US | disclosed |
| EP-4270008-B1 | METHOD OF CHARACTERISING A TARGET POLYPEPTIDE USING A NANOPORE | OXFORD NANOPORE TECH PLC (GB) | 2026-02-04 | — | — | EP | disclosed |
| EP-4127711-B1 | METHOD OF DETECTING AN ANALYTE IN A MEDIUM COMPRISING A LIGHT SCATTERING CONSTITUENT | KING S COLLEGE LONDON (GB) | 2025-12-24 | — | — | EP | disclosed |
| EP-4662489-A1 | METHOD OF CHARACTERISING A PEPTIDE, POLYPEPTIDE OR PROTEIN USING A NANOPORE | Oxford University Innovation Limited (GB) | 2025-12-17 | — | — | EP | disclosed |
| US-20250361552-A1 | METHOD AND ADAPTORS | OXFORD NANOPORE TECHNOLOGIES PLC (GB) | 2025-11-27 | — | — | US | disclosed |
| EP-4168582-B1 | A METHOD OF SELECTIVELY CHARACTERISING A POLYNUCLEOTIDE USING A DETECTOR | OXFORD NANOPORE TECH PLC (GB) | 2025-11-19 | — | — | EP | disclosed |
| WO-2021198695-A1 | METHOD OF DETECTING AN ANALYTE IN A MEDIUM COMPRISING A LIGHT SCATTERING CONSTITUENT | KING'S COLLEGE LONDON (GB) | 2021-10-07 | — | — | WO | disclosed |
| WO-2021111125-A1 | METHOD OF CHARACTERISING A TARGET POLYPEPTIDE USING A NANOPORE | OXFORD NANOPORE TECHNOLOGIES LIMITED (GB) | 2021-06-10 | — | — | WO | disclosed |
| WO-2021111139-A1 | METHOD | OXFORD NANOPORE TECHNOLOGIES LIMITED (GB) | 2021-06-10 | — | — | WO | disclosed |
| WO-2021099801-A1 | METHOD FOR DOUBLE STRAND SEQUENCING | OXFORD NANOPORE TECHNOLOGIES LIMITED (GB) | 2021-05-27 | — | — | WO | disclosed |
| CN-112189054-A | Method of producing a composite material | 牛津纳米孔科技公司 | 2021-01-05 | — | — | CN | disclosed |
| CN-101128501-B | Epoxy resin, curable resin composition containing epoxy resin and use thereof | NIPPON KAYAKU KK | 2010-12-08 | — | — | CN | disclosed |
| CN-101128501-A | Epoxy resin, curable resin composition containing epoxy resin and use thereof | NIPPON KAYAKU KK (JP) | 2008-02-20 | — | — | CN | disclosed |
| CN-100335559-C | High optical contrast resin composition and electronic package utilizing same | IBM (US) | 2007-09-05 | — | — | CN | disclosed |
| CN-1226580-A | High optical contrast resin composition and electronic package utilizing same | IBM (US) | 1999-08-25 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260072008-A1 | METHOD OF CHARACTERISING A PEPTIDE, POLYPEPTIDE OR PROTEIN USING A NANOPORE | MAX, NPPA, NUP210 | MGLL 3182/4885HSP90AA1 2300/4885CCR6 1584/4885 |
| US-20260063618-A1 | METHOD OF CHARACTERISING A TARGET POLYPEPTIDE USING A NANOPORE | NUP210, NPPA, NUP160 | MGLL 3669/4885HSP90AA1 3144/4885CCR6 1754/4885 |
| US-20260072009-A1 | METHOD OF CHARACTERISING A TARGET POLYPEPTIDE USING A NANOPORE | NUP210, SLC9A2, SLC9A3 | MGLL 3585/4885HSP90AA1 2722/4885CCR6 3030/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.